• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals.

作者信息

Herndier B G, Werner A, Arnstein P, Abbey N W, Demartis F, Cohen R L, Shuman M A, Levy J A

机构信息

Department of Pathology, San Francisco General Hospital, California.

出版信息

AIDS. 1994 May;8(5):575-81. doi: 10.1097/00002030-199405000-00002.

DOI:10.1097/00002030-199405000-00002
PMID:7520247
Abstract

OBJECTIVE

To characterize a Kaposi's sarcoma (KS) cell line established from a tumor biopsy from the oral mucosa of an iatrogenically immunosuppressed HIV-negative man.

METHODS

Cells were placed in culture and evaluated by a variety of biologic, serologic, karyotypic, and immunologic procedures. Electron microscopic examination was performed. The ability to produce tumors in nude mice was evaluated, and the nature of the cells within the tumor determined. Assays for urokinase plasminogen activator type (uPA), plasminogen activator inhibitor-1 (PAI-1) and the urokinase receptor (uPAR) were conducted.

RESULTS

The SLK cell line has an endothelial cell morphology with very little anaplasia. The karyotype indicates diploid phenotype of human origin. Immunohistochemical and electron microscopic examinations confirmed the endothelial nature of this cell line. No viruses were detected. The tumors induced in nude mice showed hypervascularization, with characteristics of KS. The cell line produces uPA and PAI-1, and also expresses uPAR.

CONCLUSIONS

The SLK cell line is of endothelial cell origin and the first human cell line to induce KS-like tumors in recipient animals. The expression of urokinase and its receptor suggests a paracrine and autocrine interaction that may be important for the growth of the tumor. The SLK line should be valuable for studies of KS pathogenesis and therapeutic approaches to this malignancy.

摘要

相似文献

1
Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals.
AIDS. 1994 May;8(5):575-81. doi: 10.1097/00002030-199405000-00002.
2
The urokinase plasminogen activator system in angiosarcoma, Kaposi's sarcoma, granuloma pyogenicum, and angioma: an immunohistochemical study.血管肉瘤、卡波西肉瘤、脓性肉芽肿和血管瘤中尿激酶纤溶酶原激活物系统:一项免疫组织化学研究。
Int J Dermatol. 2000 Mar;39(3):188-91. doi: 10.1046/j.1365-4362.2000.00950.x.
3
Spindle cells isolated from Kaposi's sarcoma-like lesions of BKV/tat-transgenic mice co-express markers of different cell types.从BKV/tat转基因小鼠的卡波西肉瘤样病变中分离出的梭形细胞共表达不同细胞类型的标志物。
AIDS. 1996 Sep;10(11):1211-9. doi: 10.1097/00002030-199609000-00006.
4
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.尿激酶型纤溶酶原激活剂、其受体及1型尿激酶型纤溶酶原激活剂抑制剂对卡波西肉瘤和毛细血管内皮细胞体外生长及侵袭的影响:HIV-Tat蛋白的作用
Int J Oncol. 2005 Jul;27(1):223-35.
5
Plasminogen activator system in oral squamous cell carcinoma.口腔鳞状细胞癌中的纤溶酶原激活物系统
Br J Oral Maxillofac Surg. 2007 Dec;45(8):623-7. doi: 10.1016/j.bjoms.2007.04.021. Epub 2007 Jun 21.
6
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.纤溶酶原激活物抑制剂-1作为乳腺癌血管重塑的一项指标
J Pathol. 2001 Sep;195(2):236-43. doi: 10.1002/path.931.
7
Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.尿激酶、尿激酶受体和纤溶酶原激活物抑制剂-1的联合过表达与乳腺癌进展相关:正常、良性和恶性乳腺组织的免疫组织化学比较
Cancer. 1996 Mar 15;77(6):1079-88. doi: 10.1002/(sici)1097-0142(19960315)77:6<1079::aid-cncr12>3.0.co;2-z.
8
Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.成釉细胞瘤中尿激酶型纤溶酶原激活物(uPA)、尿激酶型纤溶酶原激活物受体(uPAR)、纤溶酶原激活物抑制剂-1(PAI-1)和乳腺丝抑蛋白(maspin)的免疫组织化学检测
J Oral Pathol Med. 2007 Sep;36(8):488-94. doi: 10.1111/j.1600-0714.2007.00554.x.
9
The significance of urokinase- type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer.尿激酶型纤溶酶原激活剂及其抑制剂和受体在上皮性卵巢癌患者腹水中的意义。
Cancer. 1995 Apr 1;75(7):1627-33. doi: 10.1002/1097-0142(19950401)75:7<1627::aid-cncr2820750712>3.0.co;2-v.
10
[Comparison of urokinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in primary resection of oral squamous cell carcinoma].[尿激酶型纤溶酶原激活剂(uPA)与纤溶酶原激活剂抑制剂(PAI-1)在口腔鳞状细胞癌原发切除术中的比较]
Mund Kiefer Gesichtschir. 2004 May;8(3):180-90. doi: 10.1007/s10006-003-0519-3. Epub 2004 Feb 6.

引用本文的文献

1
Molecular Mechanisms of KSHV Latency Establishment and Maintenance.卡波西肉瘤相关疱疹病毒潜伏感染的建立与维持的分子机制
Curr Clin Microbiol Rep. 2024 Dec;11(4):220-230. doi: 10.1007/s40588-024-00232-x. Epub 2024 Jul 19.
2
Mapping herpesvirus-driven impacts on the cellular milieu and transcriptional profile of Kaposi sarcoma in patient-derived mouse models.在患者来源的小鼠模型中,绘制疱疹病毒对卡波西肉瘤细胞环境和转录谱的影响。
bioRxiv. 2024 Sep 28:2024.09.27.615429. doi: 10.1101/2024.09.27.615429.
3
iTIME.219: An Immortalized KSHV Infected Endothelial Cell Line Inducible by a KSHV-Specific Stimulus to Transition From Latency to Lytic Replication and Infectious Virus Release.
iTIME.219:一种永生化的卡波西肉瘤相关疱疹病毒(KSHV)感染的内皮细胞系,可通过KSHV特异性刺激诱导从潜伏状态转变为裂解复制并释放感染性病毒。
Front Cell Infect Microbiol. 2021 Apr 14;11:654396. doi: 10.3389/fcimb.2021.654396. eCollection 2021.
4
A conserved Eph family receptor-binding motif on the gH/gL complex of Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus.Eph 家族受体结合模序在卡波氏肉瘤相关疱疹病毒和恒河猴疱疹病毒 gH/gL 复合物上的保守性。
PLoS Pathog. 2018 Feb 12;14(2):e1006912. doi: 10.1371/journal.ppat.1006912. eCollection 2018 Feb.
5
RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature.RNA测序显示卡波西肉瘤相关疱疹病毒感染模拟缺氧基因表达特征。
PLoS Pathog. 2017 Jan 3;13(1):e1006143. doi: 10.1371/journal.ppat.1006143. eCollection 2017 Jan.
6
Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.核内先天性免疫DNA传感器IFI16在卡波西肉瘤相关疱疹病毒(KSHV)裂解激活过程中被降解:IFI16在维持KSHV潜伏中的作用。
J Virol. 2016 Sep 12;90(19):8822-41. doi: 10.1128/JVI.01003-16. Print 2016 Oct 1.
7
A Toolbox for Herpesvirus miRNA Research: Construction of a Complete Set of KSHV miRNA Deletion Mutants.疱疹病毒微小RNA研究工具箱:一套完整的卡波西肉瘤相关疱疹病毒微小RNA缺失突变体的构建
Viruses. 2016 Feb 19;8(2):54. doi: 10.3390/v8020054.
8
KSHV MicroRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation.卡波西肉瘤相关疱疹病毒微小RNA抑制原肌球蛋白1并增加非锚定依赖性生长和内皮管形成。
PLoS One. 2015 Aug 11;10(8):e0135560. doi: 10.1371/journal.pone.0135560. eCollection 2015.
9
Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.下一代测序分析揭示了卡波西肉瘤相关疱疹病毒感染细胞中miRNA-mRNA靶对的差异表达谱。
PLoS One. 2015 May 5;10(5):e0126439. doi: 10.1371/journal.pone.0126439. eCollection 2015.
10
Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.卡波西肉瘤相关疱疹病毒复制与发病机制研究的最新进展
Virol Sin. 2015 Apr;30(2):130-45. doi: 10.1007/s12250-015-3595-2. Epub 2015 Apr 23.